Boston Research & Management Inc. has filed a Form 13F-HR/A with the Securities and Exchange Commission, disclosing its equity holdings as of June 30, 2025. The filing lists a total of 117 distinct positions held by the firm.
The largest holding in the portfolio is Microsoft Corporation, with 20,642,277 shares. Other significant positions include NVIDIA Corporation with 6,221,649 shares, Apple Inc. with 11,785,598 shares, and Berkshire Hathaway Inc. Class B with 9,226,959 shares. The filing also lists substantial stakes in Johnson & Johnson, Visa, Procter & Gamble, and Eli Lilly & Co.
The portfolio is diversified across various sectors, including technology, healthcare, consumer goods, and energy. Major holdings in the technology sector include Apple, Microsoft, NVIDIA, and Broadcom. Healthcare positions include Eli Lilly, Merck & Co., and Medtronic. The consumer sector is represented by Procter & Gamble, Coca-Cola, and PepsiCo.
The filing also includes significant allocations to exchange-traded funds (ETFs). The iShares Core S&P 500 ETF holds 18,393,514 shares, while the iShares Core S&P 500 ETF (IDV) holds 11,614,740 shares. Other notable ETF positions include the iShares Core S&P 500 ETF (IVV) with 11,614,740 shares and the iShares Core S&P 500 ETF (VOO) with 11,614,740 shares.
The filing does not indicate any changes in the number of shares held for any of the listed positions. The filing was signed by Daniel F. Tortola, CFA, the Chief Investment Officer of Boston Research & Management Inc.
